10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026

American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A. +19 more·2026·Diabetes Care

DOI 10.2337/dc26-s010

Cites (298)

Items 201–332 of 332

Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
Weber, Michael A., Bakris, George L., Jamerson, Kenneth, Weir, Matthew, Kjeldsen, Sverre E., Devereux, Richard B., Velazquez, Eric J., Dahlöf, Björn, Kelly, Roxzana Y., Hua, Tsushung A. et al. · 2010 · Journal of the American College of Cardiology
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Makani, H., Bangalore, S., Desouza, K. A., Shah, A., Messerli, F. H. · 2013 · BMJ
Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
McAllister, David A., Read, Stephanie H., Kerssens, Jan, Livingstone, Shona, McGurnaghan, Stuart, Jhund, Pardeep, Petrie, John, Sattar, Naveed, Fischbacher, Colin, Kristensen, Soren Lund et al. · 2018 · Circulation
Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis
Michael D. Miedema, Daniel A. Duprez, Jeffrey R. Misialek, Michael Joseph Blaha, Khurram Nasir, Michael G. Silverman, Ron Blankstein, Matthew Jay Budoff, Philip Greenland, Aaron R. Folsom · 2014 · Circulation Cardiovascular Quality and Outcomes
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
Fitchett, David, Butler, Javed, van de Borne, Philippe, Zinman, Bernard, Lachin, John M, Wanner, Christoph, Woerle, Hans J, Hantel, Stefan, George, Jyothis T, Johansen, Odd Erik et al. · 2018 · European Heart Journal
A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial
Feldman, Ross D., Zou, Guang Y., Vandervoort, Margaret K., Wong, Cindy J., Nelson, Sigrid A.E., Feagan, Brian G. · 2009 · Hypertension
Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial
Lindholt, Jes S, Søgaard, Rikke · 2017 · The Lancet
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
Helen Martina Colhoun, D.J. Betteridge, P Durrington · 2004 · ACC Current Journal Review
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Roeters van Lennep, Jeanine E, Tokgözoğlu, Lale S, Badimon, Lina, Dumanski, Sandra M, Gulati, Martha, Hess, Connie N, Holven, Kirsten B, Kavousi, Maryam, Kayıkçıoğlu, Meral, Lutgens, Esther et al. · 2023 · European Heart Journal
Consistency With the DASH Diet and Incidence of Heart Failure
Levitan, Emily B., Wolk, Alicja, Mittleman, Murray A. · 2009 · Archives of Internal Medicine
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Bi, Yufang, Li, Mian, Liu, Yan, Li, Tingzhi, Lu, Jieli, Duan, Peng, Xu, Fengmei, Dong, Qijuan, Wang, Ailiang, Wang, Tiange et al. · 2025 · New England Journal of Medicine
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Birkeland, Kåre I., Bodegard, Johan, Eriksson, Jan W., Norhammar, Anna, Haller, Hermann, Linssen, Gerard C.M., Banerjee, Amitava, Thuresson, Marcus, Okami, Suguru, Garal‐Pantaler, Elena et al. · 2020 · Diabetes, Obesity and Metabolism
Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS–TIMI 54
Bhatt, Deepak L., Bonaca, Marc P., Bansilal, Sameer, Angiolillo, Dominick J., Cohen, Marc, Storey, Robert F., Im, Kyungah, Murphy, Sabina A., Held, Peter, Braunwald, Eugene et al. · 2016 · Journal of the American College of Cardiology
Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis
Malik, Shaista, Zhao, Yanglu, Budoff, Matthew, Nasir, Khurram, Blumenthal, Roger S., Bertoni, Alain G., Wong, Nathan D. · 2017 · JAMA Cardiology
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA <sup>®</sup> )
Marx, Nikolaus, Rosenstock, Julio, Kahn, Steven E, Zinman, Bernard, Kastelein, John J, Lachin, John M, Espeland, Mark A, Bluhmki, Erich, Mattheus, Michaela, Ryckaert, Bart et al. · 2015 · Diabetes and Vascular Disease Research
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
Nilsson, Erik, Gasparini, Alessandro, Ärnlöv, Johan, Xu, Hairong, Henriksson, Karin M., Coresh, Josef, Grams, Morgan E., Carrero, Juan Jesus · 2017 · International Journal of Cardiology
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
Bhatt, Deepak L, Steg, Philippe Gabriel, Mehta, Shamir R, Leiter, Lawrence A, Simon, Tabassome, Fox, Kim, Held, Claes, Andersson, Marielle, Himmelmann, Anders, Ridderstråle, Wilhelm et al. · 2019 · The Lancet
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials
Thomopoulos, Costas, Parati, Gianfranco, Zanchetti, Alberto · 2017 · Journal of Hypertension
Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis
Pignone, Michael, Earnshaw, Stephanie, Tice, Jeffrey A., Pletcher, Mark J. · 2006 · Annals of Internal Medicine
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial
Webster, Ruth, Salam, Abdul, de Silva, H. Asita, Selak, Vanessa, Stepien, Sandrine, Rajapakse, Senaka, Amarasekara, Stanley, Amarasena, Naomali, Billot, Laurent, de Silva, Arjuna P. et al. · 2018 · JAMA
Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate
Qiao, Yao, Shin, Jung-Im, Chen, Teresa K., Inker, Lesley A., Coresh, Josef, Alexander, G. Caleb, Jackson, John W., Chang, Alex R., Grams, Morgan E. · 2020 · JAMA Internal Medicine
Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies
Olmastroni, Elena, Molari, Giulia, De Beni, Noemi, Colpani, Ornella, Galimberti, Federica, Gazzotti, Marta, Zambon, Alberto, Catapano, Alberico L, Casula, Manuela · 2022 · European Journal of Preventive Cardiology
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
Cheeley, Mary Katherine, Saseen, Joseph J., Agarwala, Anandita, Ravilla, Sudha, Ciffone, Nicole, Jacobson, Terry A., Dixon, Dave L., Maki, Kevin C. · 2022 · Journal of Clinical Lipidology
Microvascular disease, peripheral artery disease, and amputation
Beckman, Joshua A., Duncan, Meredith S., Damrauer, Scott M., Wells, Quinn S., Barnett, Joey V., Wasserman, David H., Bedimo, Roger J., Butt, Adeel A., Marconi, Vincent C., Sico, Jason J. et al. · 2019 · Circulation
Peripheral arterial disease detection, awareness, and treatment in primary care
Ayal Hirsh, Michael H. Criqui, Diane Treat‐Jacobson · 2002 · ACC Current Journal Review
Contribution of Major Lifestyle Risk Factors for Incident Heart Failure in Older Adults
Del Gobbo, Liana C., Kalantarian, Shadi, Imamura, Fumiaki, Lemaitre, Rozenn, Siscovick, David S., Psaty, Bruce M., Mozaffarian, Dariush · 2015 · JACC: Heart Failure
Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
Giugliano, Robert P., Pedersen, Terje R., Saver, Jeffrey L., Sever, Peter S., Keech, Anthony C., Bohula, Erin A., Murphy, Sabina A., Wasserman, Scott M., Honarpour, Narimon, Wang, Huei et al. · 2020 · Stroke
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial
Colucci, Wilson S., Kolias, Theodore J., Adams, Kirkwood F., Armstrong, William F., Ghali, Jalal K., Gottlieb, Stephen S., Greenberg, Barry, Klibaner, Michael I., Kukin, Marrick L., Sugg, Jennifer E. · 2007 · Circulation
Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project
Bandak, Ghassan, Sang, Yingying, Gasparini, Alessandro, Chang, Alex R., Ballew, Shoshana H., Evans, Marie, Arnlov, Johan, Lund, Lars H., Inker, Lesley A., Coresh, Josef et al. · 2017 · Journal of the American Heart Association
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Bonaca, Marc P, Catarig, Andrei-Mircea, Houlind, Kim, Ludvik, Bernhard, Nordanstig, Joakim, Ramesh, Chethana Kalmady, Rasouli, Neda, Sourij, Harald, Videmark, Alex, Verma, Subodh · 2025 · The Lancet
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction
Exner, Derek V, Dries, Daniel L, Waclawiw, Myron A, Shelton, Brent, Domanski, Michael J · 1999 · Journal of the American College of Cardiology
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial
Ray, Kausik K., Stoekenbroek, Robert M., Kallend, David, Nishikido, Toshiyuki, Leiter, Lawrence A., Landmesser, Ulf, Wright, R. Scott, Wijngaard, Peter L. J., Kastelein, John J. P. · 2019 · JAMA Cardiology
Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry
Echouffo-Tcheugui, Justin B., Xu, Haolin, DeVore, Adam D., Schulte, Phillip J., Butler, Javed, Yancy, Clyde W., Bhatt, Deepak L., Hernandez, Adrian F., Heidenreich, Paul A., Fonarow, Gregg C. · 2016 · American Heart Journal
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
Bhatt, Deepak L., Eikelboom, John W., Connolly, Stuart J., Steg, P. Gabriel, Anand, Sonia S., Verma, Subodh, Branch, Kelley R.H., Probstfield, Jeffrey, Bosch, Jackie, Shestakovska, Olga et al. · 2020 · Circulation
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Moriarty, Patrick M., Jacobson, Terry A., Bruckert, Eric, Thompson, Paul D., Guyton, John R., Baccara-Dinet, Marie T., Gipe, Daniel · 2014 · Journal of Clinical Lipidology
PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis
Khan, Safi U, Yedlapati, Siva H, Lone, Ahmad N, Hao, Qiukui, Guyatt, Gordon, Delvaux, Nicolas, Bekkering, Geertruida E (Trudy), Vandvik, Per Olav, Riaz, Irbaz Bin, Li, Sheyu et al. · 2022 · BMJ
Blood pressure targets for hypertension in people with diabetes mellitus
Arguedas, Jose Agustin, Leiva, Viriam, Wright, James M · 2013 · Cochrane Database of Systematic Reviews
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
Zhang, Chunyu, Sun, Aijun, Zhang, Peng, Wu, Chaoneng, Zhang, Shuning, Fu, Mingqiang, Wang, Keqiang, Zou, Yunzeng, Ge, Junbo · 2010 · Diabetes Research and Clinical Practice
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Nissen, Steven E., Menon, Venu, Nicholls, Stephen J., Brennan, Danielle, Laffin, Luke, Ridker, Paul, Ray, Kausik K., Mason, Denise, Kastelein, John J. P., Cho, Leslie et al. · 2023 · JAMA
Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes
Pandey, Ambarish, Vaduganathan, Muthiah, Patel, Kershaw V., Ayers, Colby, Ballantyne, Christie M., Kosiborod, Mikhail N., Carnethon, Mercedes, DeFilippi, Christopher, McGuire, Darren K., Khan, Sadiya S. et al. · 2021 · JACC: Heart Failure
Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men
Al-Delaimy, Wael K, Merchant, Anwar T, Rimm, Eric B, Willett, Walter C, Stampfer, Meir J, Hu, Frank B · 2004 · The American Journal of Medicine
The progression from hypertension to congestive heart failure
1997 · ACC Current Journal Review
Sex Differences in Diabetes and Risk of Incident Coronary Artery Disease in Healthy Young and Middle-Aged Adults
Rita Rastogi Kalyani, Mariana Lazo, Pamela Ouyang, Evrim Bengi Turkbey, Karinne Chevalier, Frederick L. Brancati, Diane M. Becker, Dhananjay M. Vaidya · 2013 · Diabetes Care
Peripheral Arterial Disease, Diabetes, and Mortality
Leibson, Cynthia L., Ransom, Jeanine E., Olson, Wayne, Zimmerman, Bruce R., O’Fallon, W. Michael, Palumbo, Pasquale J. · 2004 · Diabetes Care
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
Pratley, Richard E., Tuttle, Katherine R., Rossing, Peter, Rasmussen, Søren, Perkovic, Vlado, Nielsen, Olav Wendelboe, Mann, Johannes F.E., MacIsaac, Richard J., Kosiborod, Mikhail N., Kamenov, Zdravko et al. · 2024 · Journal of the American College of Cardiology
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of <scp>SOUL</scp> , a randomized trial
McGuire, Darren K., Busui, Rodica P., Deanfield, John, Inzucchi, Silvio E., Mann, Johannes F. E., Marx, Nikolaus, Mulvagh, Sharon L., Poulter, Neil, Engelmann, Mads D. M., Hovingh, G. Kees et al. · 2023 · Diabetes, Obesity and Metabolism
Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65–74 years from a population screening study (VIVA trial)
Grøndal, N, Søgaard, R, Lindholt, J S · 2015 · British Journal of Surgery
Effects of physical activity and sedentary time on the risk of heart failure
Young, Deborah Rohm, Reynolds, Kristi, Sidell, Margo, Brar, Somjot, Ghai, Nirupa R., Sternfeld, Barbara, Jacobsen, Steven J., Slezak, Jeffrey M., Caan, Bette, Quinn, Virginia P. · 2014 · Circulation: Heart Failure
Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial
Upadhya, Bharathi, Rocco, Michael, Lewis, Cora E., Oparil, Suzanne, Lovato, Laura C., Cushman, William C., Bates, Jeffrey T., Bello, Natalie A., Aurigemma, Gerard, Fine, Lawrence J. et al. · 2017 · Circulation: Heart Failure
Is "Isolated Home" Hypertension as Opposed to "Isolated Office" Hypertension a Sign of Greater Cardiovascular Risk?
Bobrie, Guillaume, Genès, Nathalie, Vaur, Laurent, Clerson, Pierre, Vaisse, Bernard, Mallion, Jean-Michel, Chatellier, Gilles · 2001 · Archives of Internal Medicine
Pregnancy Outcomes in Familial Hypercholesterolemia: A Registry-Based Study
Toleikyte, Ieva, Retterstøl, Kjetil, Leren, Trond Paul, Iversen, Per Ole · 2011 · Circulation
Effects of Cuff Size on the Accuracy of Blood Pressure Readings
Junichi Ishigami, Jeanne B. Charleston, Edgar R. Miller · 2023 · JAMA Internal Medicine
Adherence to a Mediterranean Diet is Associated With Reduced Risk of Heart Failure in Men
Tektonidis, Thanasis G., Åkesson, Agneta, Gigante, Bruna, Wolk, Alicja, Larsson, Susanna C. · 2016 · European Journal of Heart Failure
Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis
Mao, Yaqian, Lin, Wei, Wen, Junping, Chen, Gang · 2020 · BMJ Open Diabetes Research & Care
Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum
Honigberg, Michael C., Zekavat, Seyedeh M., Pirruccello, James P., Natarajan, Pradeep, Vaduganathan, Muthiah · 2021 · Journal of the American College of Cardiology
Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: Updated Systematic Review and Meta-Analysis
X. Xie, E. Atkins, J. Lv · 2016 · Journal of Vascular Surgery
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
G�de, P., Hildebrandt, P., Hess, G., Parving, H.-H., Pedersen, O. · 2005 · Diabetologia
Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?
Khunti, Kamlesh, Kosiborod, Mikhail, Ray, Kausik K. · 2018 · Diabetes, Obesity and Metabolism
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines
Paul Kieran Whelton, Robert M. Carey, Giuseppe Mancia, Reinhold Hugo Kreutz, Joshua D. Bundy, Bryan Williams · 2022 · European Heart Journal
High Prevalence of Peripheral Arterial Disease and Low Treatment Rates in Elderly Primary Care Patients with Diabetes
Lange, S., Diehm, C., Darius, H., Haberl, R., Allenberg, J., Pittrow, D., Schuster, A., von Stritzky, B., Tepohl, G., Trampisch, H. · 2004 · Experimental and Clinical Endocrinology & Diabetes
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray, Kausik K, Nicholls, Stephen J, Li, Na, Louie, Michael J, Brennan, Danielle, Lincoff, A Michael, Nissen, Steven E · 2024 · The Lancet Diabetes & Endocrinology
Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity
Matthew M.Y. Lee, Nazim Ghouri, Anoop Misra, Yu Mi Kang, Martin K. Rutter, Hertzel C. Gerstein, Darren K. McGuire, Naveed A. Sattar · 2025 · Diabetes Care
Effects of Canagliflozin on Amino-Terminal Pro–B-Type Natriuretic Peptide
Januzzi, James L., Xu, Jialin, Li, JingWei, Shaw, Wayne, Oh, Richard, Pfeifer, Michael, Butler, Javed, Sattar, Naveed, Mahaffey, Kenneth W., Neal, Bruce et al. · 2020 · Journal of the American College of Cardiology
Achieving Goal Blood Pressure in Patients With Type 2 Diabetes: Conventional Versus Fixed‐Dose Combination Approaches
Bakris, George L., Weir, Matthew R., on behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators · 2003 · The Journal of Clinical Hypertension
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population. Follow-up Results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study
Sega R., Rita Facchetti, M. Bombelli, G. Cesana · 2005 · ACC Current Journal Review
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension
Phillips, Robert A., Xu, Jiaqiong, Peterson, Leif E., Arnold, Ryan M., Diamond, Joseph A., Schussheim, Adam E. · 2018 · Journal of the American College of Cardiology
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
Angiolillo, Dominick J., Baber, Usman, Sartori, Samantha, Briguori, Carlo, Dangas, George, Cohen, David J., Mehta, Shamir R., Gibson, C. Michael, Chandiramani, Rishi, Huber, Kurt et al. · 2020 · Journal of the American College of Cardiology
Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
Anna Kezerashvili, Kevin Phillip Marzo, Joshua De Leon · 2012 · Current Cardiology Reviews
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Nelson, Adam J., O’Brien, Emily C., Kaltenbach, Lisa A., Green, Jennifer B., Lopes, Renato D., Morse, Caryn G., Al-Khalidi, Hussein R., Aroda, Vanita R., Cavender, Matthew A., Gaynor, Tanya et al. · 2022 · JAMA Network Open
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
Basu, Sanjay, Sussman, Jeremy B., Rigdon, Joseph, Steimle, Lauren, Denton, Brian T., Hayward, Rodney A. · 2017 · PLOS Medicine
Cardiovascular Outcomes Using Doxazosin vs. Chlorthalidone for the Treatment of Hypertension in Older Adults With and Without Glucose Disorders: A Report From the ALLHAT Study
Barzilay, Joshua I., Davis, Barry R., Bettencourt, Judy, Margolis, Karen L., Goff, David C., Black, Henry, Habib, Gabriel, Ellsworth, Allan, Force, Rex W., Wiegmann, Thomas et al. · 2004 · The Journal of Clinical Hypertension
Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies
Botha, Theunis C., Pilcher, Gillian J., Wolmarans, Karen, Blom, Dirk J., Raal, Frederick J. · 2018 · Atherosclerosis
Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial
Segar, Matthew W., Patel, Kershaw V., Vaduganathan, Muthiah, Caughey, Melissa C., Butler, Javed, Fonarow, Gregg C., Grodin, Justin L., McGuire, Darren K., Pandey, Ambarish · 2020 · Diabetes Care
Oral semaglutide and cardiovascular outcomes in people with type 2 diabetes, according to SGLT2i use: prespecified analyses of the SOUL randomized trial
Marx, Nikolaus, Deanfield, John E., Mann, Johannes F.E., Arechavaleta, Rosario, Bain, Stephen C., Bajaj, Harpreet S., Bayer Tanggaard, Katrine, Birkenfeld, Andreas L., Buse, John B., Davicevic-Elez, Zaklina et al. · 2025 · Circulation
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.
Weng, Wayne, Tian, Ye, Kong, Sheldon X., Ganguly, Rahul, Hersloev, Malene, Brett, Jason, Hobbs, Todd · 2019 · Endocrinology, Diabetes & Metabolism
Diabetes Mellitus and Risk of New-Onset and Recurrent Heart Failure: A Systematic Review and Meta-Analysis
Kodama*, Satoru, Fujihara, Kazuya, Horikawa, Chika, Sato, Takaaki, Iwanaga, Midori, Yamada, Takaho, Kato, Kiminori, Watanabe, Kenichi, Shimano, Hitoshi, Izumi, Tohru et al. · 2020 · ESC Heart Failure
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
Lee, Matthew M.Y., Sattar, Naveed, Pop-Busui, Rodica, Deanfield, John, Emerson, Scott S., Inzucchi, Silvio E., Mann, Johannes F.E., Marx, Nikolaus, Mulvagh, Sharon L., Poulter, Neil R. et al. · 2025 · Diabetes Care
Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia
Maki, Kevin C., Guyton, John R., Orringer, Carl E., Hamilton-Craig, Ian, Alexander, Dominik D., Davidson, Michael H. · 2016 · Journal of Clinical Lipidology
Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis
Guo, Ru, Li, Nian, Yang, Rong, Liao, Xiao-Yang, Zhang, Yu, Zhu, Ben-Fu, Zhao, Qian, Chen, Lingmin, Zhang, Yong-Gang, Lei, Yi · 2021 · Frontiers in Nutrition
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
Musso, Giovanni, Sircana, Antonio, Saba, Francesca, Cassader, Maurizio, Gambino, Roberto · 2020 · PLOS Medicine
Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension: A Systematic Review and Meta-analysis
Wang, Nelson, Rueter, Phidias, Atkins, Emily, Webster, Ruth, Huffman, Mark, de Silva, Asita, Chow, Clara, Patel, Anushka, Rodgers, Anthony · 2023 · JAMA Cardiology
The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes
Ronald B Goldberg, Neil J. Stone, Scott M. Grundy · 2020 · Diabetes Care
Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
Ana Palanca, Falco van Nes, Felipe Pardo, Francisco Javier Ampudia‐Blasco, Chantal Mathieu · 2022 · Diabetes Care
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
Agarwala, Anandita, Dixon, Dave L., Gianos, Eugenia, Kirkpatrick, Carol F., Michos, Erin D., Satish, Priyanka, Birtcher, Kim K., Braun, Lynne T., Pillai, Priyamvada, Watson, Karol et al. · 2024 · Journal of Clinical Lipidology
Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial
Jarolim, Petr, White, William B., Cannon, Christopher P., Gao, Qi, Morrow, David A. · 2018 · Diabetes Care
Network meta-analysis of randomized trials evaluating the comparative efficacy of lipid-lowering therapies added to maximally tolerated statins for the reduction of low-density lipoprotein cholesterol
Toth, Peter P., Bray, Sarah, Villa, Guillermo, Palagashvili, Tamara, Sattar, Naveed, Stroes, Erik S. G., Worth, Gavin M. · 2022 · Journal of the American Heart Association
Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations
de Boer, Ian H., Bakris, George, Cannon, Christopher P. · 2018 · JAMA
Diabetes and Progression of Heart Failure
Echouffo-Tcheugui, Justin B., Ndumele, Chiadi E., Zhang, Sui, Florido, Roberta, Matsushita, Kunihiro, Coresh, Josef, Skali, Hicham, Shah, Amil M., Selvin, Elizabeth · 2022 · Journal of the American College of Cardiology
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
Lincoff, A. Michael, Wolski, Kathy, Nicholls, Stephen J., Nissen, Steven E. · 2007 · JAMA
Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
Meek, Claire, Wierzbicki, Anthony S., Jewkes, Christina, Twomey, Patrick J., Crook, Martin A., Jones, Alan, Viljoen, Adie · 2012 · Current Medical Research and Opinion
Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies
Adhikari, Anish, Tripathy, Swetapadma, Chuzi, Sarah, Peterson, Jonna, Stone, Neil J. · 2021 · Journal of Clinical Lipidology
Pravastatin in preeclampsia: A meta-analysis and systematic review
Mészáros, Balázs, Veres, Dániel Sándor, Nagyistók, Luca, Somogyi, Anikó, Rosta, Klára, Herold, Zoltán, Kukor, Zoltán, Valent, Sándor · 2023 · Frontiers in Medicine
Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials
De Filippo, Ovidio, D’Ascenzo, Fabrizio, Iannaccone, Mario, Bertaina, Maurizio, Leone, Attilio, Borzillo, Irene, Ravetti, Emanuele, Solano, Andrea, Pagliassotto, Ilaria, Nebiolo, Marco et al. · 2023 · Cardiovascular Diabetology
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Robert H. Knopp, on behalf of the ASPEN Study Group · 2006 · Diabetes Care
Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
Samia Mora, Jeffrey M. Ames, JoAnn E. Manson · 2016 · JAMA
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
Jia, Xiaoming, Al Rifai, Mahmoud, Ramsey, David J., Ahmed, Sarah T., Akeroyd, Julia M., Nambi, Vijay, Ballantyne, Christie M., Petersen, Laura A., Stone, Neil J., Virani, Salim S. · 2019 · The American Journal of Medicine
First-line diuretics versus other classes of antihypertensive drugs for hypertension
Reinhart, Marcia, Puil, Lorri, Salzwedel, Douglas M, Wright, James M · 2023 · Cochrane Database of Systematic Reviews
Effects of aspirin for primary prevention in persons with diabetes mellitus: the ASCEND Study Collaborative Group
Louise J. Bowman, Marion M. Mafham, Karl Wallendszus · 2018 · Journal of Vascular Surgery
Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification
Rana, Jamal S., Virani, Salim S., Moffet, Howard H., Liu, Jennifer Y., Coghlan, Landis A., Vasadia, Jitesh, Ballantyne, Christie M., Karter, Andrew J. · 2022 · The American Journal of Medicine
Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)
Adam J. Nelson, Ann Marie Návar, Hillary S. Mulder, DANIEL M. WOJDYLA, Sephy Philip, Craig B. Granowitz, Eric David Peterson, Neha Jadeja Pagidipati · 2020 · The American Journal of Cardiology
Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: the Thousand & 1 Study
Rørth, Rasmus, Jørgensen, Peter Godsk, Andersen, Henrik Ullits, Christoffersen, Christina, Gøtze, Jens Peter, Køber, Lars, Rossing, Peter, Jensen, Magnus Thorsten · 2020 · European Journal of Endocrinology
Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus
Aukelien C. Dimitriu‐Leen, Arthur J.H.A. Scholte, Alexander R. van Rosendael, Inge J. van den Hoogen, A. V. Kharagjitsingh, Ron Wolterbeek, Juhani M. Knuuti, Lucia J.M. Kroft, Victoria Delgado, J. Wouter Jukema et al. · 2015 · The American Journal of Cardiology
Microvascular disease increases the risk of lower limb amputation – A Western Danish cohort study
Olesen, Kevin Kris Warnakula, Anand, Sonia, Thim, Troels, Gyldenkerne, Christine, Maeng, Michael · 2022 · European Journal of Clinical Investigation
Introduction: Standards of Care in Diabetes—2024 Abridged for Primary Care Professionals
Nuha A. ElSayed, Arshiya A. Baig, Sarah Bradley et al. · 2024 · Clinical Diabetes
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis
Andrew J. Krentz, Stephan Jacob, Christian Heiß, Naveed A. Sattar, Soo Kyung Lim, Kamlesh K. Khunti, Robert H. Eckel · 2024 · Atherosclerosis
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center
Tran, Christine, Vo, Victoria, Taylor, Perry, Koehn, Deborah A., Virani, Salim S., Dixon, Dave L. · 2022 · Journal of Clinical Lipidology
Early aspirin discontinuation after coronary stenting: a systematic review and meta-analysis
Wiebe, Jens, Ndrepepa, Gjin, Kufner, Sebastian, Lahmann, Anna L., Xhepa, Erion, Kuna, Constantin, Voll, Felix, Gosetti, Rosanna, Laugwitz, Karl‐Ludwig, Joner, Michael et al. · 2021 · Journal of the American Heart Association
Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men
Wael K. Al‐Delaimy, Anwar T. Merchant, Eric B. Rimm · 2004 · ACC Current Journal Review
Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events
Smolderen, Kim G., Ameli, Omid, Chaisson, Christine E., Heath, Kevin, Mena-Hurtado, Carlos · 2022 · AJPM Focus
Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies
D. Panagiotakos, C. Antza, V. Kotsis · 2023 · Journal of Hypertension
Efficacy of renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in hypertensive patients with diabetes: subgroup analysis based on albuminuria in a systematic review and meta-analysis
Ichikawa, Daisuke, Kawarazaki, Wakako, Saka, Sanae, Kanaoka, Tomohiko, Ohnishi, Hirofumi, Arima, Hisatomi, Shibata, Shigeru · 2025 · Hypertension Research
The Nevada peripheral artery disease screening effort in a Medicare Advantage population and subsequent mortality and major adverse cardiovascular event risk
Smolderen, Kim G., Heath, Kevin, Scherr, Terry, Bauzon, Samuel R., Howell, Amy Nguyen, Mena-Hurtado, Carlos · 2022 · Journal of Vascular Surgery
<scp>Meta‐analysis</scp> of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin
McMurray, John J. V., Solomon, Scott D., Lock, J. Paul, Massaro, Joseph M., Zhu, Fang, Zhou, Wenjiong, Skali, Hicham, Lewis, Eldrin F., Freeman, Mason W., Halvorsen, Yuan‐Di C. · 2024 · Diabetes, Obesity and Metabolism
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial
Kang, Yu Mi, Giugliano, Robert P., Ran, Xinhui, Deedwania, Prakash, De Ferrari, Gaetano M., George, Jyothis T., Gouni-Berthold, Ioanna, Paiva da Silva Lima, Gabriel, Handelsman, Yehuda, Lewis, Basil S. et al. · 2025 · Diabetes Care
Effects of oral semaglutide on cardiovascular outcomes: A systematic review and meta-analysis
Rebelo, Thiago Gorayeb, de Araujo Paysano, Maria Lúcia Brito, Matheus, Gustavo Tadeu Freitas Uchôa, Ribeiro, Danilo Monteiro, Said, Thomas Benevides, Kelly, Francinny Alves · 2025 · International Journal of Cardiology
Effect of a Multifactorial Intervention on Mortality in Type II Diabetes
P. Gaede, H. Lund-Andersen, Hans‐Henrik Parving · 2008 · Journal of Vascular Surgery
Population Screening and Intervention for Vascular Disease in Danish Men (VIVA): A Randomised Controlled Trial
Jes Sanddal Lindholt, Rikke Søgaard · 2017 · Journal of Vascular Surgery
Statin use and risk of dementia and Alzheimer’s disease: A meta-analysis of observational studies
Elena Olmastroni, Federica Galimberti, Margherita Gazzotti, A. Zambon, Alberico Luigi Catapano, Matteo Casula · 2022 · Atherosclerosis
Bempedoic Acid for Primary Prevention of Cardiovascular Events—Reply
Steven E. Nissen, Stephen James Nicholls, Abraham Michael Lincoff · 2023 · JAMA
1991-LB: Cardiovascular Efficacy of Evolocumab in Persons with Type 1 Diabetes Mellitus—Insights from FOURIER Trial
Yu Mi Kang, Robert Patrick Giugliano, Xinhui Ran, PRAKASH C. DEEDWANIA, Gaetano Maria De Ferrari, Jyothis Thomas George, Ioanna Gouni‐Berthold, Gabriel Paiva da Silva Lima, Yehuda Handelsman, Basil S. Lewis et al. · 2025 · Diabetes
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
Rodica Pop-Busui, James L Januzzi, Dennis Bruemmer · 2022
CARDIOVASCULAR AND RENAL OUTCOMES ACROSS THE GLYCEMIC SPECTRUM: INSIGHTS FROM THE UK BIOBANK
Michael Honigberg, Seyedeh M. Zekavat, James Pirruccello · 2021 · Journal of the American College of Cardiology
Corrigendum to “Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis” [Atherosclerosis, Vol 396, (September 2024), 118528]
Andrew Krentz, Stephan Jacob, Christian Heiss · 2024 · Atherosclerosis
AMBULATORY AND HOME BLOOD PRESSURE MONITORING FOR CARDIOVASCULAR DISEASE RISK EVALUATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE COHORT STUDIES
Demosthenes Panagiotakos, Christina Antza, Vasilios Kotsis · 2024 · Journal of Hypertension
Corrigendum: Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis
Ru Guo, Nian Li, Rong Yang · 2021 · Frontiers in Nutrition
Shared Decision Making Regarding Aspirin in Primary Prevention of Cardiovascular Disease—Reply
Samia Mora, JoAnn E. Manson · 2016 · JAMA
Secondary Prevention of Macro Vascular Events in Patients With Type II Diabetes in the PROactive Study (PROspective Pioglitazone Clinical Trial and Macro Vascular Events): A Randomised Controlled Trial
J.A. Dormandy, B. Charbonnel, D.J.A. Eckland · 2006 · Journal of Vascular Surgery
Optimal medical therapy with or without PCI for stable coronary disease
W.E. Boden, R.A. O’Rourke, K.K. Teo · 2007 · Journal of Vascular Surgery
The Prevention of Progression of Arterial Disease and Diabetes (POPADAD) Trial: Factorial Randomised Placebo Controlled Trial of Aspirin and Antioxidants in Patients with Diabetes and Asymptomatic Peripheral Arterial Disease
J. Belch, A. MacCuish, I. Campbell · 2009 · Journal of Vascular Surgery
Rivaroxaban in Peripheral Artery Disease After Revascularization
M.P. Bonaca, R.M. Bauersachs, S.S. Anand, E.S. Debus, M.R. Nehler, M.R. Patel · 2020 · Journal of Vascular Surgery
Triglyceride-Lowering Therapies Reduce Cardiovascular Disease Event Risk in Subjects with Hypertriglyceridemia
Kevin C. Maki, Michael H. Davidson, John R. Guyton, Carl E. Orringer, Ian Hamilton-Craig, Dominik D. Alexander · 2015 · Journal of Clinical Lipidology
The Nevada peripheral artery disease screening effort in a Medicare Advantage population and subsequent mortality and major adverse cardiovascular event risk
Kim G. Smolderen, Kevin Heath, Terry Scherr, Samuel R. Bauzon, Amy Nguyen Howell, Carlos Mena-Hurtado · 2022 · European Journal of Vascular and Endovascular Surgery